Impact of COVID-19 on Economy, Industry and Company :
The emergence of novel coronavirus has affected the global economy, industry dynamics and company’s top line. The entire ecosystem has to suffer the impact of this pandemic disease which would result in significant demand & supply gap, production delay and weak consumer demand of end products across industries. At Bizizz Market Research, our analyst has done extensive research across industries and identify various methodologies which would assist C-Level executive to counter this ongoing threat and make informed business decision.
Kindly contact us to know more details: https://www.bizizzmarketresearch.com/contact
Global Amlodipine Besylate Market was Valued at US$ XX Bn in 2019 and it is Expected to Reach More than US$ XX Bn by 2028, Likely to Grow with the CAGR of 4.1% During the Forecast Period.
Amlodipine Besylate is a calcium channel blocker by relaxing blood vessels so blood can flow more easily. Amlodipine is also used in the treatment of chest pain (angina), high blood pressure (hypertension) in adults and children at least 6 years old, and other conditions caused by coronary artery disease. It works by Lowering high blood pressure helps prevent heart attacks, strokes, and kidney problems.
Increasing Aging Population And Rise In Prevalence Of Heart Diseases Due To Changing Lifestyle Is Anticipated To Drive The Demand For Amlodipine Besylate
A rise in the prevalence of heart diseases such as heart attack, stroke, atherosclerosis, and a rising number of lifestyle diseases are also contributing to the growth of global demand for Amlodipine Besylate. According to WHO, Europe followed by North America has witnessed the highest cholesterol level. The rising number of diabetic patients holds immense potential to the growth of the global Amlodipine Besylate market.
Furthermore, a rise in the geriatric population, an increase in healthcare expenditure in emerging regions along with an increase in R&D activities in the field of pharmaceutical industries, modern healthcare amenities, and various cholesterol related healthcare campaigns is expected to boost demand for Amlodipine Besylate globally.
However, stringent regulations, side effects of Amlodipine Besylate such as Dizziness, lightheadedness, swelling ankles/feet, can act as a restrain of the market.
5 mg Tablet Segment Held a Significant Share in Global Amlodipine Besylate Market in 2019
On the basis of Product Type, the tablet segment held a significant share in the Amlodipine Besylate Market, accounted for over XX% of the global revenue share of the Amlodipine Besylate Market in 2019. And expected to grow at a significant CAGR of XX% during the forecast period. The Amlodipine Besylate 5 mg tablet is usually an initial dose in the treatment of both hypertension and Chest pain i.e.angina.
High Blood Pressure Segment is Expected to Witness Highest Growth in the Global Amlodipine Besylate Market across the Globe
High Blood Pressure segment is estimated to be the largest application of the Amlodipine Besylate market. It is projected to grow at the highest rate in the Amlodipine Besylate market during the forecast period owing to increasing incidences of hypertension due to changing lifestyles. According to the estimates published by the World Health Organization (WHO) in 2019, around 1.15 billion people globally have hypertension, and it is a major cause behind premature death worldwide.
The North America Is Expected to Significant the Amlodipine Besylate Market During the Forecast Period
North America accounted for over XX% of the global revenue share of the Amlodipine Besylate market in 2019 and this trend is expected to continue over the forecast period. High prevalence of heart disease in North America attributed to the lack of physical activity, smoking, control of cholesterol, increased body weight, blood sugar, and lack of a healthy diet.
Market in Asia Pacific region is Anticipated to Grow at Significant Rate During the Forecast Period.
The Amlodipine Besylate market in the Asia Pacific is an emerging market, accounted for over XX% of global revenue share in 2019 and is anticipated to expand at a XX% CAGR during the forecast period due to increase in the incidence of cardiovascular diseases, hypertension and changes in health care regulatory policies and large generic population.
In addition, the presence of highly populated countries including India and China and increasing awareness about heart-related problems is also supporting the growth of the market in the region. Japan, China, and India are expected to be the fastest-growing Amlodipine Besylate markets in Asia.
Key players operating in the global Amlodipine Besylate market are Pfizer, Mylan, Apotex, Teva Pharmaceutical, Dr. Reddy's Laboratories, Cipla, Hikma Pharmaceuticals, Sun Pharmaceutical, Aurobindo Pharma, Lupin Pharmaceuticals, Strides Pharma, Upsher-Smith Laboratories, InvaGen Pharmaceuticals
Amlodipine Besylate Market Key Segments:
Amlodipine Besylate Market, By Product Type
- 2.5mg Tablets
- 5mg Tablets
- 10mg Tablets
Amlodipine Besylate Market, By Application
- High Blood Pressure
- Heart Disease
Amlodipine Besylate Market, By Region
- North America
- Asia Pacific
- Middle east and Africa
- Latin America